SANA - Sana Biotechnology, Inc. Common Stock

Day 1m 10m 60m PreMarket Market AfterHours Gap
6.35 -0.35 (-5.51%) 0.06 (1.01%) 0.06 (1.01%) -0.18 (-2.91%) -0.35 (-5.51%) 1.41 (31.15%) -0.01 (-0.24%) 0.09 (1.52%)

Sana Biotechnology Inc is a biotechnology company. The company develops engineered cells as medicines and therapies to treat diseases. It is engaged in developing cell engineering programs for across a broad array of therapeutic areas with unmet treatment needs, including oncology, diabetes, B-cell-mediated autoimmune, and central nervous system (CNS) disorders, among others. Its pipeline of product candidates is comprised of SC291, SC262, SC255, UP421 and others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)
Market Period: PreMarket

Earnings & Ratios

Basic EPS:
-0.39
Diluted EPS:
-0.39
Basic P/E:
-15.3846
Diluted P/E:
-15.3846
RSI(14) 1m:
52.38
VWAP:
5.97
RVol:
0.0575

Events

Period Kind Movement Occurred At

Related News